Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice
<jats:p>Following curative immunotherapy of B16F10 tumors, ~60% of mice develop a strong antibody response against cell-surface tumor antigens. Their antisera confer prophylactic protection against intravenous challenge with B16F10 cells, and also cross-react with syngeneic and allogeneic tumo...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021
|
| Online Access: | https://hdl.handle.net/1721.1/135528 |